# The Effect of Potassium Lowering Drugs on Cardiac Electrical Stability in Hemodialysis Patients (ART Study)

> **NCT06242041** · PHASE4 · UNKNOWN · sponsor: **Peking University First Hospital** · enrollment: 61 (estimated)

## Conditions studied

- Potassium Imbalance
- Cardiac Arrhythmia
- Dialysis; Complications

## Interventions

- **DRUG:** sodium zirconium cyclic silicate

## Key facts

- **NCT ID:** NCT06242041
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-14
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 61 (ESTIMATED)
- **Last updated:** 2024-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06242041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06242041, "The Effect of Potassium Lowering Drugs on Cardiac Electrical Stability in Hemodialysis Patients (ART Study)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06242041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*